Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,599 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia.
Vattai A, Kremer N, Meister S, Beyer S, Keilmann L, Hester A, Temelkov M, Heidegger H, Schmoeckel E, Kessler M, Mahner S, Jeschke U, Hertlein L, Kolben T. Vattai A, et al. Among authors: kessler m. J Cancer Res Clin Oncol. 2022 Feb;148(2):377-386. doi: 10.1007/s00432-021-03838-6. Epub 2021 Nov 5. J Cancer Res Clin Oncol. 2022. PMID: 34739585
Epigenetic changes occur in placentas of spontaneous and recurrent miscarriages.
Meister S, Kellner I, Beyer S, Corradini S, Schulz C, Rogenhofer N, Keilmann L, Kolben TM, Mahner S, Kessler M, Jeschke U, Kolben T. Meister S, et al. Among authors: kessler m. J Reprod Immunol. 2022 Feb;149:103466. doi: 10.1016/j.jri.2021.103466. Epub 2021 Dec 14. J Reprod Immunol. 2022. PMID: 34929495
FAM111A Is a Novel Molecular Marker for Oocyte Aging.
Yang H, Kolben T, Kessler M, Meister S, Paul C, van Dorp J, Eren S, Kuhn C, Rahmeh M, Herbst C, Fink SG, Weimer G, Mahner S, Jeschke U, von Schönfeldt V. Yang H, et al. Among authors: kessler m. Biomedicines. 2022 Jan 25;10(2):257. doi: 10.3390/biomedicines10020257. Biomedicines. 2022. PMID: 35203468 Free PMC article.
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer.
Kolben T, Müller L, Meister S, Keilmann L, Buschmann C, Trillsch F, Burges A, Czogalla B, Mitter S, Schmoeckel E, Corradini S, Mahner S, Jeschke U, Kessler M, Beyer S. Kolben T, et al. Among authors: kessler m. J Cancer Res Clin Oncol. 2022 Dec;148(12):3323-3335. doi: 10.1007/s00432-022-04098-8. Epub 2022 Jun 21. J Cancer Res Clin Oncol. 2022. PMID: 35729354 Free PMC article.
High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer.
Beyer S, Müller L, Mitter S, Keilmann L, Meister S, Buschmann C, Kraus F, Topalov NE, Czogalla B, Trillsch F, Burges A, Mahner S, Schmoeckel E, Löb S, Corradini S, Kessler M, Jeschke U, Kolben T. Beyer S, et al. Among authors: kessler m. J Cancer Res Clin Oncol. 2023 Jul;149(8):4293-4303. doi: 10.1007/s00432-022-04271-z. Epub 2022 Sep 7. J Cancer Res Clin Oncol. 2023. PMID: 36068443 Free PMC article.
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells.
Kolben T, Mannewitz M, Perleberg C, Schnell K, Anz D, Hahn L, Meister S, Schmoeckel E, Burges A, Czogalla B, Hester A, Mahner S, Kessler M, Jeschke U, Corradini S, Trillsch F, Beyer S. Kolben T, et al. Among authors: kessler m. Cell Oncol (Dordr). 2022 Dec;45(6):1171-1185. doi: 10.1007/s13402-022-00708-2. Epub 2022 Sep 13. Cell Oncol (Dordr). 2022. PMID: 36098901 Free PMC article.
1,599 results